Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating expenses    
Research and development $ 329,966 $ 311,302
General and administrative 4,362,557 3,547,927
Total operating expenses 4,692,523 3,859,229
Operating loss (4,692,523) (3,859,229)
Other expense (income)    
Change in fair value of derivative liabilities 6,503,174 (767,198)
Fair value of warrant liability in excess of proceeds 7,174,634  
Financing transaction costs 137,192  
Loss on extinguishment of secured convertible promissory note - related party 590,392  
Interest expense 94,763 667
Interest income (84)  
Loss before income taxes (19,192,594) (3,092,698)
Provision for income taxes 1,642 1,600
Net loss and comprehensive loss (19,194,236) (3,094,298)
Less: Preferred deemed dividend   1,044,000
Net loss applicable to common shareholders $ (19,194,236) $ (4,138,298)
Basic and diluted net loss per common share (in dollars per share) $ (0.16) $ (0.11)
Weighted average shares of common stock outstanding: basic and diluted (in shares) 121,154,334 27,906,090